ClinConnect ClinConnect Logo
Search / Trial NCT05890625

Responsive Web-based Roadmap (InT-mAp) in Infertility Treatment

Launched by MALTEPE UNIVERSITY · Jun 5, 2023

Trial Information

Current as of November 05, 2025

Recruiting

Keywords

Infertility Web Based Education Drug Administration Treatment Success Anxiety

ClinConnect Summary

**Clinical Trial Summary: InT-mAp for Infertility Treatment**

This clinical trial is studying a new online tool called the InT-mAp, designed to help women undergoing infertility treatment, specifically those receiving assisted reproductive techniques like IVF (in vitro fertilization). The goal is to see if this web-based roadmap can improve medication management, reduce anxiety, and ultimately enhance the success of infertility treatments. Infertility can be a challenging journey, often filled with emotional and financial stress. By providing easy access to information and support through this digital platform, the trial aims to empower women and help them navigate their treatment more effectively.

To participate in this study, women should be under 35 years old and currently undergoing controlled ovarian hyperstimulation as part of their infertility treatment. They must also be able to use a smartphone and communicate effectively in Turkish. Participants can expect to receive personalized educational resources and support tailored to their needs, which may lead to better treatment outcomes and a more positive experience throughout their infertility journey. This trial is currently recruiting participants, and researchers hope that the InT-mAp will significantly improve the overall care and well-being of those facing infertility challenges.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • In vitro fertilization-Embryo transfer (IVF-ET)/ Intracytoplasmic Sperm Injection (ICSI)-ET treatment planned as assisted reproduction treatment (ART) and who are in the controlled ovarian hyperstimulation (COS) process of the treatment,
  • Having no psychological or chronic illness and related treatment that may affect the success of treatment other than the cause of infertility,
  • Primary infertile,
  • Being under 35 years old,
  • Able to speak, read and write Turkish, perceive and answer questions correctly and communicate effectively,
  • Having a smart phone with Android and the operating system for i-Phone (IOS) operating systems, being able to use mobile applications, and having sufficient equipment to use these applications (internet, etc.),
  • Women who volunteered to participate in the study will be included in the sample.
  • Exclusion Criteria:
  • Not meeting the sampling criteria,
  • Wanting to leave after the start of work,
  • Women with errors or deficiencies in their evaluation/use of the mobile application will be excluded from the study.

About Maltepe University

Maltepe University is a leading academic institution in Turkey, dedicated to advancing medical research and education. With a strong emphasis on innovative clinical practices and interdisciplinary collaboration, the university sponsors a variety of clinical trials aimed at enhancing patient care and treatment outcomes. By leveraging its state-of-the-art facilities and a network of experienced researchers, Maltepe University is committed to contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into effective therapeutic strategies.

Locations

Istanbul, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported